Keyphrases
Cardiac Resynchronization Therapy
100%
Growth Differentiation factor-15 (GDF-15)
100%
Hazard Ratio
71%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
57%
Likelihood Ratio
57%
Confidence Interval
42%
Left Ventricular Ejection Fraction
28%
Patients with Heart Failure
28%
NYHA Class
28%
Transforming Growth Factor-β
14%
Predictive Value
14%
Univariate Analysis
14%
Final Model
14%
Significant Predictors
14%
Strong Predictor
14%
Differentiation Factors
14%
Cardiomyocytes
14%
Bootstrap
14%
Internal Validity
14%
Mortality Prediction
14%
Stress Response Pathway
14%
C-statistic
14%
Cox Proportional Hazards Model
14%
Combined Measurement
14%
Multiple Stressors
14%
Biomarker Combination
14%
Nursing and Health Professions
Cardiac Resynchronization Therapy
100%
Growth Differentiation Factor 15
100%
Hazard Ratio
71%
Confidence Interval
42%
Biological Marker
28%
Heart Left Ventricle Ejection Fraction
28%
Heart Failure
28%
New York Heart Association Class
28%
Predictive Value
14%
Implant
14%
Univariate Analysis
14%
Proportional Hazards Model
14%
Transforming Growth Factor
14%
Internal Validity
14%
Bootstrapping
14%
Agricultural and Biological Sciences
Growth Differentiation Factor
100%
Confidence Interval
42%
Ejection Fraction
28%
Cytokine
14%
Endpoints
14%
Transforming Growth Factor
14%
Cardiac Muscle Cell
14%
Psychology
Hazard Ratio
100%
Univariate Statistics
20%
Proportional Hazards Regression Model
20%